Skip to content
10-Q

Quarterly Report

MACROGENICS INC MGNX

0001125345-25-000053

← back to feed
Filed
May 13, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 9, 2025 63.09M sh
Cash And Equivalents Q1 2025 · Mar 31, 2025 $145.57M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $182.84M
Stockholders Equity Q1 2025 · Mar 31, 2025 $79.12M
Stockholders Equity Q1 2025 · Dec 31, 2024 $116.06M
Current Liabilities Q1 2025 · Mar 31, 2025 $55.44M
Current Liabilities Q1 2025 · Dec 31, 2024 $55.53M
Total Liabilities Q1 2025 · Mar 31, 2025 $145.45M
Total Liabilities Q1 2025 · Dec 31, 2024 $145.6M
Current Assets Q1 2025 · Mar 31, 2025 $182.09M
Current Assets Q1 2025 · Dec 31, 2024 $217.49M
Total Assets Q1 2025 · Mar 31, 2025 $224.57M
Total Assets Q1 2025 · Dec 31, 2024 $261.66M
Cost Of Revenue Q1 2025 · Mar 31, 2025 $0
Cost Of Revenue Q1 2025 · Mar 31, 2024 $270K
Shares Diluted Q1 2025 · Mar 31, 2024 62.29M sh
Capex Q1 2025 · Mar 31, 2024 $1.46M
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$45.64M
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.84
Eps Basic Q1 2025 · Mar 31, 2024 −$0.84
Sga Expense Q1 2025 · Mar 31, 2024 $14.71M
Rd Expense Q1 2025 · Mar 31, 2024 $46.03M
Net Income Q1 2025 · Mar 31, 2024 −$52.19M
Operating Income Q1 2025 · Mar 31, 2024 −$53.75M
Revenue Q1 2025 · Mar 31, 2024 $9.1M